Showing results (151-160 of 206) with videos related to

Sort By:
Pageof 21
Annals of the Rheumatic Diseases|April 28, 2016
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritisG M Bell, A E Anderson, J Diboll, et al.
JAMA|April 29, 2015
Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment responseSebastien Viatte, Darren Plant, Buhm Han, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
CD4+ and B Lymphocyte Expression Quantitative Traits at Rheumatoid Arthritis Risk Loci in Patients With Untreated Early Arthritis: Implications for Causal Gene IdentificationNishanthi Thalayasingam, Nisha Nair, Andrew J Skelton, et al.
Rheumatology (Oxford, England)|November 6, 2023
Micro-RNA content of circulating extracellular vesicles in early rheumatoid arthritis as biomarkers and mediators of methotrexate efficacyDaniel Maunder, Philip M Brown, Ben Barron-Millar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2026
Autoreactivity vs autoimmunity: characteristics of autoantigen-specific CD4 T-cells in rheumatoid arthritis and healthJames A Stanway, Daniel Peters, Helen Waller, et al.
Arthritis Research & Therapy|April 19, 2015
Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trialJoel M Kremer, Alan J Kivitz, Jesus A Simon-Campos, et al.
BMC Biotechnology|October 14, 2003
Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletionsFrederique Ponchel, Carmel Toomes, Kieran Bransfield, et al.
Annals of the Rheumatic Diseases|January 31, 2013
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trialIain B McInnes, Joachim Sieper, Jürgen Braun, et al.
The Lancet. Rheumatology|April 30, 2021
Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trialArthur G Pratt, Stefan Siebert, Michael Cole, et al.
Genome Biology|November 2, 2016
Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23Amanda McGovern, Stefan Schoenfelder, Paul Martin, et al.
Pageof 21